Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.00% | 0.00% | 0.00% |
2020 | Abattis Bioceuticals Corp. Reports Earnings Results for the Full Year Ended September 30, 2019 | CI |
2019 | Abattis Bioceuticals Corp. Announces Board Changes | CI |
Sales 2018 | 8.37K 6.13K 512K | Sales 2019 | 357K 261K 21.81M | Capitalization | 8.62M 6.31M 527M |
---|---|---|---|---|---|
Net income 2018 | -78M -57.11M -4.77B | Net income 2019 | -3M -2.2M -183M | EV / Sales 2018 | 5,778 x |
Net cash position 2018 | 9.1M 6.66M 556M | Net cash position 2019 | 2.25M 1.65M 138M | EV / Sales 2019 | 17.8 x |
P/E ratio 2018 |
-0.57
x | P/E ratio 2019 |
-2.8
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 99.64% |
1 day | -99.00% |
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | - | 01/19/01 | |
Patrick Mitchell
COO | Chief Operating Officer | - | 01/18/01 |
Jonathan Danieli
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Cedric Wilson
BRD | Director/Board Member | - | 19/18/19 |
Patrick Mitchell
COO | Chief Operating Officer | - | 01/18/01 |
Director of Finance/CFO | - | 01/19/01 |
Date | Price | Change | Volume |
---|---|---|---|
25/24/25 | 0.000001 | -99.00% | 2,500 |
24/24/24 | 0.0001 | +9,900.00% | 700 |
Delayed Quote OTC Markets, April 25, 2024 at 09:19 pm IST
More quotes1st Jan change | Capi. | |
---|---|---|
0.00% | 476 | |
+28.87% | 272M | |
+32.92% | 261M | |
+48.84% | 194M | |
+47.54% | 131M | |
-28.57% | 121M | |
+115.91% | 119M | |
-40.53% | 119M | |
-3.85% | 86.82M | |
+150.00% | 75.33M |
- Stock Market
- Equities
- ATTBF Stock